Friedrich Gause joins AUGMENTICON

Friedrich Gause joins AUGMENTICON as Senior Vice President Finance & Strategy Development

Zurich, Switzerland – AUGMENTICONTM, a privately held Augmented-/Mixed-Reality (AR/MR-)Technology company, developing novel tools for a cost-effective, high-quality manufacturing of (radio-)pharmaceuticals, announces the appointment of Friedrich Gause as its Senior Vice President Finance and Strategy Development.

Mr. Gause will take care of developing AUGMENTICON’s corporate and business strategy and implementation plans. In this context, he will oversee and facilitate related funding rounds, investment and partnering projects of the company with a particular attention to the fast-growing Asia/Pacific region.

“We are extremely pleased that Friedrich accepted to support AUGMENTICON in its startup operations in addition to his other entrepreneurial commitments” says Matthias Friebe, Co-Founder and CEO of AUGMENTICON.

During the past 30 years, Mr. Gause held various executive positions in the pharmaceutical industry, both in Europe and in the APAC region. At this stage, he holds positions as the Managing Director or BGM Associates GmbH, and as the Chairmen of the Board of Medicinisto AG.

About AUGMENTICONTM AUGMENTICON, a driver in the application of novel INDUSTRY-4.0 solutions offers applications for the optimization of industrial radiopharmaceutical operations. The company, founded in 2019, is based in Glattbrugg/Switzerland and is developing Augmented-/Mixed-Reality based tools for a fully remote-controlled manufacturing guidance, -control, and (GMP-)documentation. It`s management has a combined 60+ years of expertise in the development, manufacturing, release, marketing, and commercialization of (radio-)pharmaceuticals. To learn more about AUGMENTICON please visit us at: